Immediate Impact

39 standout
Sub-graph 1 of 15

Citing Papers

Prevalence of sarcopenia in patients with chronic kidney disease: a global systematic review and meta‐analysis
2024 Standout
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
2024 Standout
4 intermediate papers

Works of Robert Mullan being referenced

Estimating the Prevalence of Muscle Wasting, Weakness, and Sarcopenia in Hemodialysis Patients
2019
The changing pattern of adult primary glomerular disease
2009

Author Peers

Author Last Decade Papers Cites
Robert Mullan 195 64 56 20 313
Richard J. Johnson 112 20 65 19 351
Soha Zouwail 107 42 48 21 359
Jelmer K. Humalda 180 24 52 16 292
Samra Abouchacra 86 29 78 25 283
Silvia Chiroli 88 81 43 23 323
Erkan Şengül 58 63 43 25 334
Luigi Cirillo 141 18 55 22 299
Marialuisa Querques 133 24 31 13 291
Marc Lilien 214 29 32 11 300
Cynthia T. McMurtry 66 67 51 14 308

All Works

Loading papers...

Rankless by CCL
2026